DEFA14A ·Filed Mar 13, 2026

CI

Cigna Group
NEUTRAL
Impact 3/10
Horizonimmediate Processed6mo ago SEC0001140361-26-009400
Proxy solicitation materials
Actionable Insight • Neutral

This is a routine administrative filing for an upcoming shareholder meeting. Traders should note that the vote on executive compensation is advisory and non-binding, and the shareholder proposal is likely to be defeated as it is against the board's recommendation. Monitor for any subsequent filings that may contain material financial information.

DirectionNeutral
Confidencehigh
Horizonimmediate
Final — all horizons settled through T+60d
CI ▲ +7.94% at T+60d
NEUTRAL call ✓ call won +7.94% · α vs SPY -2.54% · entry $268.31 → $289.61
Entry anchored
Mar 13, 03:59 PM ET
via exchange tick
T+1d
-1.89%
call -1.89% · α -2.16%
$263.24
settled 7mo ago
T+5d
-2.54%
call -2.54% · α -0.50%
$261.49
settled 7mo ago
T+20d
+1.34%
call +1.34% · α -2.44%
$271.91
settled 6mo ago
T+60d
+7.94%
call +7.94% · α -2.54%
$289.61
settled 4mo ago

Price Chart

Loading chart...

Executive Summary

The Cigna Group has filed its definitive proxy statement (DEFA14A) for its 2026 Annual Meeting, scheduled for April 22, 2026. The filing outlines the agenda, which includes the election of 12 directors, an advisory vote on executive compensation, ratification of the independent auditor, and a shareholder proposal on the right to act by written consent. The document was filed by the registrant (Cigna) and provides voting instructions for shareholders.

Key Facts

  • The filing is a definitive proxy statement (DEFA14A) for The Cigna Group's 2026 Annual Meeting.
  • The meeting is scheduled for April 22, 2026, and will be held virtually.
  • The agenda includes the election of 12 directors, an advisory vote on executive compensation, ratification of PricewaterhouseCoopers LLP as the independent auditor, and a shareholder proposal on the right to act by written consent.
  • The document was filed by the registrant, The Cigna Group.

Financial Impact

No direct financial impact is reported in this filing.

Risk Factors

  • The advisory vote on executive compensation, while non-binding, could signal shareholder sentiment if it fails.

Market Snapshot

Exchange
NYSE

Investment Themes

Traditional Finance

Documents Analyzed

This report is based on 4 SEC documents filed with EDGAR.

DocumentAccession Number
DEFA14A Filing (Primary)0001140361-26-009400
Document: 0001140361-26-009400-index-headers.html0001140361-26-009400
Document: 0001140361-26-009400-index.html0001140361-26-009400
Document: 0001140361-26-009400.txt0001140361-26-009400
10 reports for CI
Performance horizon

Track record builds as more directional reports settle.

Filters
Rows
Reports for CI — sortable, filterable
TypeNow
Sep 3, 2026
28d ago
144
NEUTRAL ★ 2/10
$286.26 $280.76▼ −1.92%▼ −0.77%$267.67 (−6.49%)
Aug 18, 2026
6w ago
144
NEUTRAL ★ 2/10
$278.50 $279.32▲ +0.29%▲ +0.50%$267.67 (−3.89%)
Aug 4, 2026
8w ago
144
NEUTRAL ★ 2/10
$273.45 $273.87▲ +0.16%▲ +0.25%$267.67 (−2.11%)
Jul 9, 2026
12w ago
3
NEUTRAL ★ 2/10
$293.46 $283.82▼ −3.28%▼ −2.72%$267.67 (−8.79%)
May 13, 2026
20w ago
8-K
NEUTRAL ★ 3/10
$300.42 $291.28▼ −3.04%▼ −1.88%$267.67 (−10.90%)
May 6, 2026
21w ago
Court Ruling
NEUTRAL ★ 2/10
$281.98 $300.71▲ +6.64%▲ +5.49%$267.67 (−5.07%)
Apr 30, 2026
22w ago
8-K
BULLISH ★ 7/10
$290.33 $283.65▼ −2.30%▼ −4.03%$267.67 (−7.80%)
Apr 24, 2026
23w ago
Court Ruling
NEUTRAL ★ 3/10
$275.24 $290.58▲ +5.57%▲ +4.67%$267.67 (−2.75%)
Mar 13, 2026
28w ago
DEFA14A
NEUTRAL ★ 3/10
$268.31 $261.49▼ −2.54%▼ −0.50%$267.67 (−0.24%)
Feb 27, 2026
31w ago
8-K
NEUTRAL ★ 4/10
$289.40 $271.04▼ −6.34%▼ −4.36%$267.67 (−7.51%)
Showing 10 of 10

US Market Status

Market Open — Closes in 6h 25m

Subscribe to SecBot

Get Real-Time SEC Filing Intelligence

Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.

Try SecBot Free Coming soon: SecBot Pro with alerts, watchlists, and API access